88 results about "Early cirrhosis" patented technology

The invention discloses a blood marker for diagnosing hepatic fibrosis and early cirrhosis. The blood marker refers to galectin 3. The concentration of the galectin 3 in the blood is analyzed by using the blood marker through enzyme linked immune reaction so as to analyze and evaluate hepatic fibrosis and early cirrhosis. By using the blood as the detection sample, early diagnosis on hepatic fibrosis and early cirrhosis can be achieved conveniently and rapidly.

The invention relates to a medicine for hepatic fibrosis and early cirrhosis treatment, belonging to Chinese herbal medicine, which comprises ten to twenty grams of bupleurum chinense, fifteen to thirty grams of red sage root, fifteen to twenty grams of turmeric root-tuber, ten to twenty grams of curcuma zedoariae, twenty to thirty grams of turtle shell, fifteen to twenty grams of rhizome corydalis, ten to twenty grams of costus roots, fifteen to twenty grams of largehead atractylodes rhizome, fifteen to twenty grams of fructus forsythiae, fifteen to twenty grams of alisma orientale, twenty to thirty grams of hiraute shiny bugleweed herb and twenty to thirty grams of fructus polygoni orientalis.

The invention relates to a traditional Chinese medicine used for treating hepatitis B, and specifically relates to a traditional Chinese medicine composition used for treating hepatitis B, wherein the medicine is prepared from Chinese herbal medicines. The traditional Chinese medicine is prepared from the medicine materials of: 15g of Chinese thorowax root, 10g of Baikal skullcap root, 10g of figwortflower picrorhiza rhizome, 10g of banksian rose, 30g of red peony root, 10g of raw rhubarb, 30g of capillary wormwood herb, 15g of male fern rhizome, 15g of asiabell root, and 15g of Mongolian milkvetch root. The traditional Chinese medicine used for treating hepatitis B has functions of liver soothing, qi regulating, heat clearing, dampness removing, blood cooling, detoxifying, pathogen eliminating, and qi supporting. The medicine provides substantial treatment effects against chronic hepatitis B and early-stage liver cirrhosis.

The invention relates to an anti-aging honey. 6-7?times?amount?of?water is added into selected traditional Chinese medicine raw materials, filtrate without precipitates is mixed with honey according to the weight ratio of 1:1.6-2.5, the mixture is concentrated until the content of the traditional Chinese medicines is 5-15% and then the concentrated mixture is fed to bees, bees take the mixture, honey is collected and poisonous impurities are removed from the honey, so that the anti-aging honey is obtained. The honey containing various kinds of traditional Chinese medicines are decomposed and made under action of biological enzymes of bees, and the test shows that the content of various beneficial?components is higher than 5-10 times that of the common honey. Various traditional Chinese medicines capable of tonifying and nourishing liver are added into the honey raw materials, so that the anti-aging honey has obvious efficacies of protecting liver and obvious therapy effect on chronic hepatitis and early chronic hepatitis. The anti-aging honey does not has any toxic and side effects, and is convenient to take and suitable for long-term?administration?of patients.

The medicine for treating acute and chronic hepatitis B is prepared with 11 kinds of Chinese medicinal materials including pseudostellaria root, trogopterus dung, red sage, chicken's gizzard membrane, taraxacum, etc. The medicine can regulate immunological cell and liver function, excite body to produce interferon to inhibit the virus replication inside the liver, killing virus gene HBV-DNA to inhibit re-combination of hepatitis B virus and promote blood circulation to eliminate blood stasis. It has stable curative effect and no any toxic side effect. It has also high curative effect on early stage hepatocirrhosis.

The medicine for treating acute and chronic hepatitis B is prepared with 11 kinds of Chinese medicinal materials including pseudostellaria root, trogopterus dung, red sage, chicken's gizzard membrane, taraxacum, etc. The medicine can regulate immunological cell and liver function, excite body to produce interferon to inhibit the virus replication inside the liver, killing virus gene HBV-DNA to inhibit re-combination of hepatitis B virus and promote blood circulation to eliminate blood stasis. It has stable curative effect and no any toxic side effect. It has also high curative effect on early stage hepatocirrhosis.

The invention provides pure traditional Chinese medicine pills for treating hepatitis and a preparation method thereof. The pure traditional Chinese medicine pills are prepared from the following crude drugs: radix paeoniae alba, oldenlandia diffusa, polygonum cuspidatum, astragalus membranaceus, periostracum cicada, radix pseudostellariae, radix salviae miltiorrhizae, silkworm larva, radix sophorae flavescentis, radix bupleuri, stir-frying turtle shell with vinegar, poria cocos, Chinese wolfberries, human placenta, oriental wormwood, felwort, dandelion, sedum sarmentosum, radix rehmanniae recen, schisandra chinensis, ligusticum wallichii, isatis root, hawthorn, abrus cantoniensis hance, rhizoma atractylodis macrocephalae and liquorice. The crude drugs are used together to bring out the best in each other and have the efficacies of reinforcing qi and nourishing blood, protecting liver and reducing enzyme, clearing heat and promoting dieresis, soothing liver-qi stagnation, dispersing blood stasis and detoxifying, regulating liver and tonifying spleen, removing heat from the liver and benefiting gallbladder, detoxifying and eliminating acute communicable diseases; the pure traditional Chinese medicine pills can effectively restrain hepatitis C virus, have remarkable curative effect for negativing surface antigen of hepatitis B and reducing enzyme, contribute to recovering liver function, improve the immunity, have the efficacy of softening liver to remove stasis, are simple in preparation method, short in pharmacy course of treatment, small in toxic or side effect, easy to produce and low in cost, and facilitate large-scale popularization.

A drug for treating early cirrhosis ascites is prepared according to a routine preparation method by 18-30 parts of lanceolata, 20-40 parts of astragalus, 13-20 parts of deep-fried atractylodes, 13-20 parts of tangerine peel, 13-20 pars of Chinese yam, 12-18 parts of areca peel, 13-20 parts of wolfiporia cocos, 10-16 parts of sparganium, 10-16 parts of curcuma rhizome, 12-18 parts of citrus aurantium, 10-16 parts of magnolia cortex, 9-15 parts of rhubarb, 12-15 parts of eucommia, 15-20 parts of flos caryophyllata, 12-15 parts of costus root, 12-15 parts of curcuma tuber, 12-15 parts of coptis, 12-15 parts of scutellaria, 12-15 parts of phellodendron, 15-25 parts of artemisia capillaries, 12-15 parts of alpinia officinarum hance, 20-25 parts of each component of Jiaosanxian, 12-15 parts of faeces trogopterpri, 12-15 parts of rhizoma corydalis, 6-10 parts of licorice, 13-20 parts of plantain seed, 20-25 pars of fenugreek seed, and 15-20 parts of gardenia. The drug of the invention has the efficacy of invigorating energy and elevating yang, supplementing qi and generating body fluid, diuresis and detumence, drying moisture and alleviating water retention, relieving pain and expelling pus, and has a high cure rate when treating early cirrhosis ascites with few side effects on human body.

The invention relates to the field of detection technology and particularly discloses a direct quantitative detection kit for alpha-ketoglutaric acid in human serum. The direct quantitative detection kit comprises a serum sub-packaging tube, a hepes buffer solution, a reducing coenzyme, an enzyme stabilizer, a fluorescent dye and an alpha-KG standard. The kit disclosed by the invention can quickly and efficiently detect alpha-ketoglutaric acid in the serum of patients suffering from liver cirrhosis and liver cancer, thereby providing a technical guarantee for detecting and screening patients suffering from early liver cirrhosis and liver cancer. Compared with the traditional chromatography coupled detection method, nuclear magnetic resonance method and the like, the kit disclosed by the invention is low in cost and simple to operate and has the characteristics of high speed and high throughput; the kit for detecting alpha-ketoglutaric acid in serum has specific selectivity and relatively high stability; and compared with a biological detection method, the kit is obviously improved in operation repeatability, can be used as an effective tool for diagnosing liver cirrhosis and liver cancer, is of great significance to early detection of liver diseases and evaluation of treatment effects, and has broad application prospects.